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Summary
Background.— While cardiologists are very active in the prevention of cardiovascular disease,
their attitudes towards patients’ smoking habits are poorly studied.
Aims.— In a nationwide French survey, we assessed cardiologists’ levels of knowledge and
management of smoking cessation.
Methods.— We sent out a questionnaire to a random sample of 1000 cardiologists.
Results.— A total of 371 cardiologists agreed to participate in the survey; 8.1% were current
smokers and 32.4% were past smokers. Most classiﬁed smoking cessation as the top priority
for patients with coronary artery disease (56.5%) and peripheral arterial disease (88.5%). Car-
diologists routinely assessed active and passive smoking in 96.2% and 43% of their patients,
respectively. Only 29.2% considered themselves well informed about smoking-cessation man-
agement. While 39.9% declared they knew about the minimal counselling 7.3% described it
correctly. Only 17.5% used the Fagerström questionnaire. Smoking cessation was advised sys-
tematically by 85% but only 5.4% of cardiologists followed up their patients speciﬁcally on
this issue. They referred smokers to either their general practitioner or to smoking-cessation
centres and/or quitlines in 16.0% and 67.0% of cases, respectively; 31.8% never referred their
patients to a smoking-cessation centre, and 25% declared being unaware of any such centre in
their area. Cardiologists who smoked were less likely to ask about patients’ smoking status than
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MOTS CLÉS
Tabagisme ;
Cardiologue ;
Prise en charge
est faible. Leur propre statut tabagique conditionne leur attitude face à la prise en charge du
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bbreviations
AD coronary artery disease
RT nicotine replacement therapy
AD peripheral arterial disease
CC smoking cessation centre
ackground
moking is considered to be one of the major risk factors
or cardiovascular diseases. In the INTERHEART study, smok-
ng corresponded to 35.7% of the population-attributable
isk for acute myocardial infarction worldwide [1]. After
cardiovascular event, smoking-cessation counselling is
ffective in reducing smoking rates [2] and has a signiﬁ-
ant beneﬁcial effect on mortality [3]. Smoking cessation
emains the most cost-effective therapeutic strategy for
educing long-term mortality and morbidity [4,5]. Despite
his, the EuroAspire surveys, conducted between 1995 and
005, showed that almost 25% of smokers in France still
ontinue to smoke 6months after a myocardial infarction
nd this rate remained appallingly unchanged throughout
his period [6]. In contrast, rates of adequate control for
yslipidaemia improved substantially over the same period
6]. on SAS.
In this nationwide study, we sought to assess cardiolo-
ists’ attitudes towards patients’ smoking habits in France.
e hypothesized that cardiologists’ levels of knowledge and
nvolvement in smoking-cessation strategies are poor. We
lso hypothesized that their own smoking status inﬂuences
he cardiologists’ level of involvement in managing smoking
essation in their patients.
ethods
n April 2007, we mailed a questionnaire to 1000 cardiolo-
ists in France. They were randomly selected from a list of
ore than 6000 names in the 2007 professional directory of
he Fédération franc¸aise de cardiologie.
The following topics were assessed in the questionnaire:
the priority of risk-factors management in patients with
coronary, peripheral and cerebral artery diseases;
assessment of smoking status; smoking rates; cardi-
ologists’ level of knowledge about smoking-cessation
counselling and therapies;
cardiologists’ level of involvement in the managementV. Aboyans et al.
non-smokers (90% vs 98.2%, p = 0.039). Similarly, they were more passive in offering smoking-
cessation counselling (23% vs 7%, p = 0.011), and referred less frequently their patients to a
smoking-cessation centre (37% vs 64%, p = 0.028).
Conclusion.— French cardiologists are rarely involved in the management of smoking cessation.
Their own smoking status inﬂuences their attitudes towards the management of smoking
cessation.
© 2009 Published by Elsevier Masson SAS.
Résumé
Justiﬁcation.— Les cardiologues sont très actifs pour prendre en charge les facteurs de risque
cardiovasculaires, mais leurs attitudes face au tabagisme sont mal connues.
Objectifs.— Nous avons voulu connaître les connaissances et attitudes des cardiologues franc¸ais
face au tabagisme.
Méthodes.— Nous avons envoyé un questionnaire à un échantillon aléatoire de 1000 cardio-
logues.
Résultats.— Parmi eux, 371 ont répondu (8 % fumeurs, 32 % ex-fumeurs). Les cardiologues
classent en majorité l’arrêt de tabac comme la première priorité chez les coronariens (56,5 %)
et les artériopathes (88,5 %). Le tabagisme actif et passif sont systématiquement recherchés
dans 96 % et 43 % des cas. Seuls 29 % se considèrent bien informés pour cette prise en charge.
Si 39 % déclarent connaître le conseil minimal, seuls 7 % le décrivent correctement. Seuls 18 %
utilisent le questionnaire de Fagerström. S’ils conseillent systématiquement l’arrêt de tabac
dans 85 % des cas, seuls 5 % suivent un patient spéciﬁquement à cet effet. Ils orientent leurs
patients vers le médecin traitant dans 16 % des cas et vers un tabacologue ou ligne téléphonique
d’assistance dans 67 % des cas, mais 32 % n’adressent jamais un patient vers un tabacologue et
25 % ne connaissent pas de tabacologues dans leurs zones d’activité. Les cardiologues fumeurs
interrogent plus rarement leurs patients sur leur tabagisme (90% vs 98 % pour les non-fumeurs,
p = 0,039) et les adressent moins souvent vers un tabacologue (37 % vs 64 %, p = 0,028).
Conclusions.— L’implication des cardiologues franc¸ais dans la prise en charge du tabagismeof smoking cessation, and their collaboration with other
healthcare providers.
The cardiologists were also asked to declare their
wn smoking status. The time required to complete the
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Table 1 Characteristics of participating cardiologists.
Characteristic Mean± S.D. or n (%)a
Age (years) 49.8± 8.8
Men, n (%) 306 (83.4)
Years in practice 20.8± 9.4
Type of practice, n (%)
Private practice exclusively 161 (43.3)
Public hospitals exclusively 106 (28.7)
Private and public practice 104 (28.0)
Location, n (%)
Paris and the surrounding area 65 (17.5)
Elsewhere (in
France) > 100,000
inhabitants
134 (36.1)
Elsewhere (in
France) < 100,000
inhabitants
172 (46.4)
Speciality, n (%)
Clinical cardiology 285 (77)
Cardiac/coronary
catheterization
42 (11.4)
Arrhythmia, pacing 24 (6.5)
Cardiac rehabilitation 19 (5.1)
Perform vascular exploration,
n (%)
185 (50.5)
Smoking status, n (%)
Non-smokers 220 (59.3)
Past smokers 120 (32.4)
Current smokersa 30 (8.1)
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aPercentages calculated according to total number of responses
for each item (missing responses excluded).
questionnaire was estimated at 20minutes. No ﬁnancial
compensation was offered.
The results are presented as mean± S.D. for continuous
variables and number (percentage) for categorical variables.
The 2 test and Student’s t-test were performed when appli-
cable. A p-value of less than 0.05 was considered to be
statistically signiﬁcant. Statview 4.0 (SAS Institute, Cary,
NC, USA) statistical software was used.
Results
Out of 1000 cardiologists who were sent the questionnaire,
371 completed it (Table 1). Overall, 40% of the cardiologists
were ever smokers (80% past smokers). Past smokers were
older than non-smokers (51.8± 8.2 years vs 48.9± 9.0 years,
p = 0.048) and current smokers (49.8± 8.5 years, p = 0.054).
Smoking cessation as a priority in secondary
preventionCardiologists were asked to classify the management of ﬁve
modiﬁable risk factors (dyslipidaemia, hypertension, smok-
ing, obesity, sedentary lifestyle) in three clinical situations:
a patient with CAD, a patient with a PAD, and a patient who
i
T
c
sigure 1. Ranking of smoking cessation relative to four other
odiﬁable risk factors (dyslipidaemia, hypertension, obesity,
edentary lifestyle) in patients with coronary artery disease (CAD),
eripheral arterial disease (PAD) and stroke.
ad had a stroke. A majority classiﬁed smoking cessation as
he top priority for patients with CAD and PAD (Fig. 1). No
tatistically signiﬁcant differences were reported in rank-
ng according to the respondent’s smoking status (data not
hown).
Cardiologists estimated that 55% of their patients had
topped smoking following an acute cardiovascular event.
owever, cardiologists who smoked reported a mean quit-
ing rate of 66%, which was signiﬁcantly higher than rates
eported by those who were non-smokers (54.6%, p = 0.003)
r past smokers (53.5%, p = 0.007).
ssessment of smoking habits
early all of the cardiologists (n = 357, 96.2%) always
ssessed their patients’ smoking status. Compared to 98.2%
f non-smokers and 94.2% of past smokers, only 90% of cardi-
logists who were smokers routinely assessed their patients’
moking status (p = 0.039 vs non-smokers). By contrast,
nly 43% of cardiologists routinely assessed passive smok-
ng among their patients. Passive smoking was ‘‘sometimes’’
ssessed by 33% of cardiologists and ‘‘rarely’’ or ‘‘never’’
ssessed by 24%.
ttitudes towards smokers
verall, cardiologists reported that 31.7% of their patients
ere smokers. Regarding their attitudes towards smokers,
majority of cardiologists (n = 315, 84.9%) regularly advised
heir patients to stop smoking, but only 20 (5.4%) of them
rovided follow-up smoking-cessation support. These two
roups were considered to offer ‘‘active’’ approaches to
moking-cessation counselling (total of 335 cardiologists,
0.3%). Conversely, 34 (9.2%) cardiologists only warned their
atients about the hazards of smoking and two (0.5%) rarely
iscussed smoking cessation with patients who smoked;
hese cardiologists were considered to have ‘‘passive’’
pproaches to smoking-cessation counselling.
Non-smoker cardiologists followed an active approach
n 92.7% of cases, similar to 89.2% in past smokers.
his contrasted with 76.7% of cardiologists who were
urrent smokers (p = 0.011 vs non-smokers, p = 0.12 vs past-
mokers).
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Oigure 2. Cardiologists’ smoking status and their attitudes
owards offering patients smoking-cessation counselling.
When asked who they consider to be the most appropriate
erson to offer smoking-cessation counselling, 27.5% of car-
iologists said themselves, with no difference in response
ates according to their own smoking status. Overall,
moking-cessation centres (46%) and general practitioners
33%) were considered the most appropriate healthcare
roviders for offering smoking-cessation counselling.
Cardiologists were also questioned about their atti-
ude when a patient asks for medical support. While
majority referred their patients to a quitline service
nd/or a smoking-cessation centre (Fig. 2), cardiologists
ho smoked were more likely to refer these patients to their
eneral practitioner than were non-smoker cardiologists
p = 0.047).
nowledge of smoking-cessation management
f the 371 cardiologists, 316 (85.2%) reported never having
eceived any speciﬁc education or training for the man-
gement of smoking cessation. Seven (1.9%) cardiologists
ad taken a university course on smoking cessation and the
emaining 48 (12.9%) participated in various programmes
f continuing medical education. The rates of special-
zed training for smoking cessation were similar in younger
≤ 50 years) and older individuals (> 50 years), at 13.1% and
7.8%, respectively (p = 0.30). In contrast, when the cardiol-
gists were asked to estimate their level of knowledge on the
anagement of smoking cessation, 108 (29.2%) considered
hemselves well informed, 191 (51.6%) partially informed,
nd 71 (19.2%) poorly informed. A total of 146 (39.4%) were
illing to participate in speciﬁc training on smoking cessa-
ion. These response rates did not differ according to their
moking status (data not shown).
International guidelines recommend that physicians
ssess the smoking status of their patients and brieﬂy advise
mokers to stop [7]. This approach, the so-called ‘‘minimal
ounselling’’, is also promoted in the French national guide-
ines [8]. The cardiologists were asked what they knew about
‘minimal counselling’’. While 148 cardiologists responded
hat they knew what the ‘‘minimal counselling’’ meant, only
p
t
t
n
2igure 3. Frequency of prescription of nicotine-replacement
herapy (NRT), bupropion and varenicline.
7 (7.3% of the total group) provided the correct answer.
one of the 30 cardiologists who smoked responded cor-
ectly.
rug prescription for smoking cessation
ig. 3 displays the prescription rates of nicotine-
eplacement therapy (NRT) and bupropion. While vareni-
line had been approved by the French Drug Agency shortly
efore the study started, and was released into the market
t the same time as the questionnaires, we asked the car-
iologists about their ‘‘intention’’ to prescribe this drug,
ather its actual prescription. Overall, the proportion of
ardiologists who would frequently prescribe these medi-
ations was low. One in ﬁve cardiologists prescribed NRT
n a regular basis. While the regular use of bupropion
as dramatically low, more cardiologists were keen to pre-
cribe varenicline during the study period. For assessment
f physical addiction, only 17.5% of cardiologists used the
agerström questionnaire [9] and 2.1% used a breath carbon
onoxide analyser.
In two open questions, we asked the participants to state
heir main criteria for deciding whether or not to prescribe
RT or bupropion. They were also asked to state the main
easons for not prescribing these medications. The ﬁve most
requent answers for each drug are presented in Table 2. A
igh level of nicotine addiction assessed by the Fagerström
uestionnaire was cited by only 19% of participants as a cri-
erion for NRT prescription. For almost 30% of cardiologists,
rescribing NRT was beyond their competence or ﬁeld of
ctivity.
ooperation with smoking-cessation centres
SCC)
verall, the cardiologists declared referring 23.6% of their
atients who smoked to a SCC. While only 31 (8.3%) rou-
inely referred their patients to a SCC, 54 (14.5%) sent more
han half of their patients to a SCC; 118 (31.8%) cardiologists
ever sent any of their patients to these centres. Notably,
5% of cardiologists were not informed about the presence of
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Table 2 Five most frequent criteria for prescribing or
avoiding nicotine-replacement therapies (NRTs) or bupro-
pion by French cardiologists.
Reasons Response
ratesa (%)
Nicotine-replacement therapies
Five main criteria for prescribing
Motivated patients 26.5
Heavy smokers 25.2
Patients’ poor willpower 24.9
High Fagerström score 19.1
Severe cardiovascular disease 11.5
Five main reasons not to prescribe
‘‘It is not my role’’ or ‘‘should
be prescribed by others’’
29.9
Patient not motivated to
undertake smoking cessation
28.2
Do not know when or how to
prescribe
6.1
Lack of efﬁcacy or useless 5.4
Unstable coronary disease 3.1
Bupropion
Five main criteria for prescribing
When NRT failed 33.3
Patients’ poor willpower 19.7
Psychiatric/mood disorders 11.1
Motivated patients 8.5
Heavy smokers 7.7
Five main reasons not to prescribe
Contraindications and adverse
effects
33.6
‘‘It is not my role’’ or ‘‘should
be prescribed by others’’
24.6
Lack of efﬁcacy or useless 13.5
Do not know when or how to
prescribe
10.7
Patient not motivated for
smoking cessation
5.2
a
Figure 4. Main criteria used by French cardiologists for referring
patients to smoking-cessation centres.
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prescribing the corresponding medication.
any SCC in their city area. Only 221 (59.6%) participants reg-
ularly collaborated with an SCC. This rate was signiﬁcantly
lower among cardiologists who smoked (36.7%) compared
with 63.6% (p = 0.009) in non-smokers and 58.3% (p = 0.04) in
past smokers.
Cardiologists who reported referring patients to SCCs
were asked to state their criteria for referral. The two
most common criteria were the patient’s motivation to stop
smoking and ‘‘hardcore’’ smokers (Fig. 4). A variety of def-
initions was used for ‘‘hardcore’’ smokers, including prior
failures to stop smoking, patients requiring close support,
large amount of daily or total tobacco smoking, strong addic-
tion, associated psychological problems and concomitant
alcohol addiction.
During the study period, a national cancer prevention
programme was introduced, with a plan to double the num-
T
l
a
aigure 5. Cardiologists’ reported experiences of smoking-
essation centres.
er of SCCs in France. When asked whether they expected
ny change in their collaboration with these centres, 68
19%) cardiologists declared that their collaboration would
emain the same 115 (32%) declared that they would
‘possibly’’ refer more patients, and 176 (49%) declared that
hey would ‘‘probably’’ refer more patients.
When asked why they did not refer their patients to
n SCC, 40% of the cardiologists reported issues in avail-
bility (e.g., appointments delays, geographical distance,
nadequate opening hours for workers); 19% of the cardi-
logists considered SCCs to be ineffective. When asked to
ualify their feedback on SCCs, most participants had pos-
tive or quite favourable experiences with patients sent to
CCs (Fig. 5).
iscussionhis study conﬁrms our main hypothesis that in our country,
evels of knowledge and involvement in the assistance
nd management of smoking cessation among cardiologists
re poor. Despite this, these cardiologists classify smoking
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essation as the top priority in preventive strategies for
atients with coronary and peripheral artery diseases.
ven though French cardiologists almost always assess their
atients’ smoking status, most do not have the ability to
ccurately counsel their patients on smoking cessation
r provide tailored medical advice to improve cessation
ates. Of note, while smoking cessation is one of the most
fﬁcient and rapid strategies to reduce further events in
atients with CAD, cardiologists considered it as a top
riority less frequently compared to patients with PAD. This
s presumably related to the importance of smoking among
AD patients, as well as the fact that preventive trials
uring the past 20 years have strongly stressed the beneﬁts
f statins in CAD patients, diverting physicians’ attention
ore towards dyslipidaemia.
A majority of participants do not systematically assess
heir patients for passive smoking, despite the fact that
econd-hand smoke can increase cardiac risk up to 30%
10,11]. It should, however, be emphasized that the propor-
ion of cardiologists who routinely assessed passive smoking
ppeared to be high. This could be explained partly by the
act that our survey was undertaken only 3months after the
ublication of a new law banning smoking in most public
laces in France.
While many of the cardiologists admitted to being
naware about basic strategies to promote smoking cessa-
ion and improve success rates, less than half were keen to
ndertake specialized training. Almost 75% did not consider
hemselves to be a ﬁrst level provider of smoking cessation
upport. It appears that French cardiologists do not per-
eive smoking-cessation counselling and support as one of
heir core areas of responsibility, and too many fail even to
elegate this task to another physician.
Compared to the high rates of use of lipid-lowering and
ntihypertensive drugs, the rate of prescription of smoking-
essation drugs appeared to be very low. The indications for
hese treatments did not appear to be clear for the cardi-
logists in our survey. Several criteria reported for the use
f drug therapies do not actually correspond to the level of
hysical addiction, but are rather related to a range of fac-
ors, from cardiovascular disease severity to the patient’s
illpower. It has been suggested that tobacco dependence
s not a priority for the pharmaceutical industry, and this
ould inﬂuence the lack of information regarding the pre-
cription of these medications [12]. Major efforts are needed
o implement specialized educational and training courses
o educate cardiologists about these drugs and their indica-
ions.
Since 2003, a full coverage of the continental French
erritory was assured by the SCC, with at least one cen-
re per administrative region. In these centres, patients
re counselled and treatments are prescribed, if needed.
ollow-up is arranged, with several consultations for up
o 1 year after effective smoking cessation, to reduce the
isk of relapse [13]. In these centres, healthcare providers
ave speciﬁc training in smoking-cessation support and
ave more dedicated time available compared with GPs
r cardiologists. In our study, the level of collaboration
etween SCCs and cardiologists (59.6%) is very similar to
hat reported by cardiologists in the United States (59.7%)
14]. While cardiologists should be more willing to refer
heir patients to these units, such referrals do not pre-
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lude the need for them to offer information about the
azards of smoking, especially in those who continue to
moke.
In this study, we found disparities in responses among car-
iologists who smoked or did not smoke. Overall, 8.1% were
ctive smokers, which is dramatically lower than the 27%
eported in the ﬁrst survey conducted in France in 1993 [15],
ut is still substantially higher than the 4.3% rate reported
or the Netherlands [16] as well as the 1.3% rate for the
nited States [17]. Compared with non-smokers, cardiolo-
ists who smoked were less likely to assess routinely their
atients’ smoking status. Our data also suggest that car-
iologists who smoked were probably too optimistic about
heir patients’ self-management of smoking cessation after
cardiovascular event. They also had a less active attitude
owards counselling and providing assistance to patients
ho smoked. In addition, cardiologists who smoked were
ess likely to offer smoking-cessation counselling to their
atients or refer them to SCCs or quitlines. Our ﬁndings sug-
est that as smokers, these cardiologists are less sensitive
bout this risk factor and are less aggressive in its manage-
ent. Overall, their attitudes might also be considered as a
enial of the importance of smoking cessation, not only for
heir patients but also in terms of their own health. The fact
hat cardiologists who were past smokers presented differ-
nt response rates to those who were active smokers but
ere similar to non-smokers also supports this hypothesis.
his attitude of ‘‘denial’’ by physicians who smoke has been
escribed in an earlier study of French cardiologists, as well
s in another survey of physicians conducted in California
18].
The major limitation of our study is that the data
re self-reported and restricted to those cardiologists who
esponded to the mailing. The 37.1% response rate is equiv-
lent to the 33.6% rate during the 1993 French survey [15],
ut lower than the 50.5% response rate obtained in a Dutch
urvey [16] and the 59% rate in an American survey [17].
e cannot exclude selection bias, with greater participa-
ion by physicians who are more interested in this topic.
ence, even our ‘‘poor’’ results should be considered as
veroptimistic. Another limitation is the low number of
ardiologists who were active smokers (n = 30), with the pos-
ibility that more differences could be revealed if a larger
roportion of smokers had participated. Finally, our ﬁndings
re only limited to our country and cannot be extrapolated
o other countries. An international cooperative study within
uropean Community countries is therefore highly recom-
ended.
onclusions
n this nationwide survey in France, we highlight major
eﬁciencies of the cardiologists in the assessment and
anagement of their patients who are smokers. In addi-
ion to the low-level of knowledge of smoking-cessation
trategies, many cardiologists are unwilling to receive
dditional training, considering that the provision of
moking-cessation support is not their primary role. Fur-
hermore, many cardiologists fail to delegate this task to
ther healthcare providers. We also found that cardiologists
ho smoked were even less involved in the assessment and
[[
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[
[
[
[
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management of patients who smoked. Past smokers had a
greater interest in the management of smoking as a risk
factor among their patients, similar to that observed among
non-smoker cardiologists. Major efforts are necessary at
national and European levels to increase awareness among
cardiologists of this important risk factor, and to improve
their understanding of smoking as a chronic disease, as well
as the effective strategies available to reduce relapse.
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